Conference Reports for NATAP

62th Annual Meeting of the American Association for the Study of Liver Diseases San Francisco 2011 Nov 6-9 Back

A US-Based Cost-Effectiveness Analysis of Boceprevir-Based Regimens in Previously Untreated Adult Subjects with Chronic Hepatitis C Genotype 1       Reported by Jules Levin AASLD Nov 5-8 2011 SF   S.A. Ferrante1*, J. Chhatwal2, E. Elbasha1, E.J. Dasbach1, A.C. El Khoury1, F. Poordad3, J-P. Bronowicki4, C.A. Brass1 1Merck Sharp & Dohme Corp., Whitehouse Station, NJ, USA, 2University of Pittsburgh, Pittsburgh, PA, USA, 3Hepatology and Liver Transplantation, Cedars-Sinai Medical Center, Los Angeles, CA, USA, 4Department of Hepato-Gastroenterology, University Hospital of Nancy, Nancy, France